Skip to main content
ELAN
NYSE Life Sciences

Elanco Guides FY Revenue to $5.16B-$5.18B

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$24.1
Mkt Cap
$11.831B
52W Low
$19.4
52W High
$27.98
52W Position info
24% above low
Off High info
14% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

ELAN sits 24% above its 52-week low of $19.4.

Summary

Elanco put a full-year revenue range of $5.16B-$5.18B on the table. That follows the Q2 2026 print of $1.37B in revenue, up 10%, when the company already raised full-year guidance, so this is the concrete number behind that raise. The range implies roughly $3.79B-$3.81B of revenue over the second half, which is the figure that matters for whether the growth trend holds. Q3 results have since come in at revenue of USD 1,265 Million versus an IBES estimate of USD 1,208 Million, with net income of $18M and adjusted EPS of 27c. For the fourth quarter, Elanco sees adjusted EPS of 16c-19c. No margin or cash flow detail came with the headline, so the quality of the revenue is still unproven, and any update to this range will settle whether the AHV acquisition and new launches are carrying the top line as advertised.

At the time of this announcement, ELAN was trading at $24.10 on NYSE in the Life Sciences sector, with a market capitalization of approximately $11.8B. The 52-week trading range was $19.40 to $27.98. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

ELAN - Latest Insights

ELAN
Nov 19, 2026, 6:35 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $27.45
Real-time Price: $25.22 info
Change: -$2.23 (-8%) info
Market Cap: $12.866B info
ELAN
Nov 06, 2026, 1:39 PM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $25.96
Real-time Price: $25.22 info
Change: -$0.7399 (-3%) info
Market Cap: $12.866B info
ELAN
Nov 06, 2026, 9:10 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $24.32
Real-time Price: $25.22 info
Change: +$0.8909 (+4%) info
Market Cap: $12.866B info
ELAN
Nov 06, 2026, 6:27 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $24.10
Real-time Price: $25.22 info
Change: +$1.12 (+5%) info
Market Cap: $12.866B info
ELAN
Aug 07, 2026, 2:20 PM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $22.53
Real-time Price: $25.22 info
Change: +$2.69 (+12%) info
Market Cap: $12.866B info